Down-regulation of amyloid precursor protein by peptide nucleic acid in vivo

Journal of Molecular Neuroscience

Volumn 24, Issue 1, 2004, Pages 123-128

  Boules, Mona ^a   Williams, Katrina ^a   Gollatz, Elisa ^a   Fauq, Abdul ^a   Richelson, Elliott ^a  

^a MAYO CLINIC   (United States)

Author keywords

Alzheimer's disease; Antisense; Peptide nucleic acid; Rat

Indexed keywords

AMYLOID PRECURSOR PROTEIN; CYSTEINYLALANYLCYSTEINYLGLYCYLALANYLTHREONYLGLYCYLCYSTEINYLTHREONYLGLYCYL CYSTEINYLCYSTEINYLCYSTEINYLALANYLGLYCINE; CYSTEINYLTHREONYLGLYCYLGLYCYLGLYCYLCYSTEINYLALANYLGLYCYLCYSTEINYLALANYL THREONYLCYSTEINYLGLYCYLTHREONYLGLYCINE; DNA; MESSENGER RNA; PEPTIDE NUCLEIC ACID; UNCLASSIFIED DRUG; PROTEIN SYNTHESIS INHIBITOR;

ALZHEIMER DISEASE; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; DNA BINDING; DOWN REGULATION; DRUG MECHANISM; IN VIVO STUDY; MALE; NONHUMAN; RAT; REGULATORY MECHANISM; RNA BINDING; WESTERN BLOTTING; ANIMAL; ARTICLE; BIOSYNTHESIS; BRAIN; DRUG ANTAGONISM; DRUG EFFECT; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; NUCLEIC ACID PROBE; PATHOPHYSIOLOGY; PHYSIOLOGY; PROTEIN SYNTHESIS; REACTION TIME; SPRAGUE DAWLEY RAT;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ANTISENSE ELEMENTS (GENETICS); BRAIN; DNA; DOWN-REGULATION; MALE; PEPTIDE NUCLEIC ACIDS; PROTEIN BIOSYNTHESIS; PROTEIN SYNTHESIS INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 16544393156     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1385/JMN:24:1:123     Document Type: Conference Paper

References (22)

1. Adlerz L., Soomets U., et al. (2003) Down-regulation of amyloid precursor protein by peptide nucleic acid oligomer in cultured rat primary neurons and astrocytes. Neurosci. Lett. 336(1), 55-59.
2. Corey D. R. (1997) Peptide nucleic acids: expanding the scope of nucleic acid recognition. Trends Biotechnol. 15(6), 224-229.
3. Demidov V. V., Potaman V. N., et al. (1994) Stability of peptide nucleic acids in human serum and cellular extracts. Biochem. Pharmacol. 48(6), 1310-1313.
4. Fraser G. L., Holmgren J., et al. (2000) Antisense inhibition of delta-opioid receptor gene function in vivo by peptide nucleic acids. Mol. Pharmacol. 57(4), 725-731.
5. Hanvey J. C., Peffer N. J., et al. (1992) Antisense and antigene properties of peptide nucleic acids. Science 258(5087), 1481-1485.
6. Hardy J. (1997) Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci. 20(4), 154-159.
7. McMahon B. M., Stewart J. A., et al. (2002) Peptide nucleic acids specifically cause antigene effects in vivo by systemic injection. Life Sci. 71(3), 325-337.
8. McMahon B. M., Stewart J. A., et al. (2001) Intraperitoneal injection of antisense peptide nucleic acids targeted to the mu receptor decreases response to morphine and receptor protein levels in rat brain. Brain Res. 904(2), 345-349.
9. Nielsen P. E., Egholm M., et al. (1993) Peptide nucleic acids (PNAs): potential antisense and anti-gene agents. Anticancer Drug Des. 8(1), 53-63.
10. Panegyres P. K. (2001) The functions of the amyloid precursor protein gene. Rev. Neurosci. 12(1), 1-39.
11. Pinnix I., Musunuru U., et al. (2001) A novel gamma secretase assay based on detection of the putative C-terminal fragment-gamma of amyloid beta protein precursor. J. Biol. Chem. 276(1), 481-487.
12. Pooga M., Soomets U., et al. (1998) Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo. Nat. Biotechnol. 16(9), 857-861.
13. Rezaei K., Xu I. S., et al. (2001) Intrathecal administration of PNA targeting galanin receptor reduces galanin-mediated inhibitory effect in the rat spinal cord. Neuroreport 12(2), 317-320.
14. Roberts G. W., Gentleman S. M., et al. (1991) Beta A4 amyloid protein deposition in brain after head trauma. Lancet 338(8780), 1422,1423.
15. Sambamurti K., Greig N. H., et al. (2002) Advances in the cellular and molecular biology of the beta-amyloid protein in Alzheimer's disease. Neuromol. Med. 1(1), 1-31.
16. Savage M. J., Trusko., S. P., et al. (1998) Turnover of amyloid beta-protein in mouse brain and acute reduction of its level by phorbol ester. J. Neurosci. 18(5), 1743-1752.
17. Selkoe D. J. (1994) Cell biology of the amyloid beta-protein precursor and the mechanism of Alzheimer's disease. Annu. Rev. Cell Biol. 10, 373-403.
18. Siman R., Card J. P., et al. (1989) Expression of beta-amyloid precursor protein in reactive astrocytes following neuronal damage. Neuron 3(3), 275-285.
19. Tyler B. M., Jansen K., et al. (1999) Peptide nucleic acids targeted to the neurotensin receptor and administered i.p. cross the blood-brain barrier and specifically reduce gene expression. Proc. Natl. Acad. Sci. U. S. A 96(12), 7053-7058.
20. Tyler B. M., McCormick D. J., et al. (1998) Specific gene blockade shows that peptide nucleic acids readily enter neuronal cells in vivo. FEBS Lett. 421(3), 280-284.
21. Tyler-McMahon B., Stewart J., et al. (2001) Altering behavioral responses and dopamine transporter protein with antisense peptide nucleic acids. Biochem. Pharmacol. 62, 929-932.
22. Wittung P., Kajanus J., et al. (1995) Phospholipid membrane permeability of peptide nucleic acid. FEBS Lett. 375(3), 27-29.